Dr. Philip T. Ninan is a distinguished member of the Editorial Advisory Board of Psychopharmacology Bulletin and currently serves as Co-Founder and Chief Executive Officer of eMind Science Corp, where he has developed eMindLog™, a neuroscience-based measure for personal self-assessment and tracking of stress, anxiety, and depression. He also serves as Adjunct Professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine.
Academic and Clinical Experience
Dr. Ninan previously served as Professor of Psychiatry and Behavioral Sciences and Director of the Mood and Anxiety Disorders Program at Emory University School of Medicine from 1983 to 2006, where he received NIMH research funding support for 22 years. From 2006 to 2012, he served as Vice President for Neuroscience, initially at Wyeth Pharmaceuticals (Global Medical Affairs) and subsequently at Pfizer (Clinical Sciences), bringing extensive pharmaceutical industry expertise to clinical development.
Research Excellence
Dr. Ninan has authored over 100 peer-reviewed journal articles in anxiety and mood disorders, and schizophrenia, with an h-index of 50. His groundbreaking work has been published in premier medical journals including Science, New England Journal of Medicine, Proceedings of the National Academy of Sciences, American Journal of Psychiatry, JAMA Psychiatry, and Journal of Clinical Psychiatry. His research focuses on psychiatric treatment response assessment and understanding the brain mechanisms that mediate therapeutic interventions.
Professional Recognition
A distinguished life fellow of the American Psychiatric Association and certified by the American Board of Psychiatry and Neurology, Dr. Ninan received the Psychiatrist of the Year award from the Georgia Psychiatric Physicians Association in 2003. He served as a Director on the national board of the American Foundation for Suicide Prevention from 2008 to 2020 and chaired the Treatment Assessment Review Committee of the National Institute of Mental Health from 1995 to 1997.
